Cargando…

A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer

BACKGROUND: Anlotinib may boost the efficacy of pancreatic cancer (PC) treatment if timely added to the GS regimen (Gemcitabine, Tegafur-gimeracil-oteracil potassium); however, no data has been published. This study evaluated the safety and efficacy of anlotinib in combination with the GS regimen(he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhan, Gouling, Hu, Jianbing, Da, Shijian, Weng, Jie, Zhou, Chuanyi, Wen, Fang, Liu, Songlian, Fang, Fang, Shen, Erdong, Zhou, Qiang, Luo, Pan, Xu, Min, Zhan, Dahe, Su, Yuqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897321/ https://www.ncbi.nlm.nih.gov/pubmed/36742383 http://dx.doi.org/10.3389/fendo.2023.1110624

Ejemplares similares

A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort
por: Zhan, Gouling, et al.
Publicado: (2023)

Efficacy and Safety of Anlotinib-Containing Regimens in Advanced Non-Small Cell Lung Cancer: A Real-World Study
por: Sun, Lei, et al.
Publicado: (2023)

The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
por: Wang, Fen, et al.
Publicado: (2021)

A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment
por: Hsieh, Tsung-Cheng, et al.
Publicado: (2023)

Partial Response After Toripalimab Plus Anlotinib for Advanced Metaplastic Breast Carcinoma: A Case Report
por: Fu, Yang, et al.
Publicado: (2022)

Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study
por: Hong, Xinyi, et al.
Publicado: (2023)

Steroidomics of Pregnant Women at Advanced Age
por: Yu, Bin, et al.
Publicado: (2022)

Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature
por: Zhang, Xi, et al.
Publicado: (2021)

Retrospective Review of Efficacy and Safety of Anlotinib in Advanced Leiomyosarcoma: A Real-World Study
por: Zou, Hanhui, et al.
Publicado: (2022)

Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting
por: Li, Jia, et al.
Publicado: (2022)

Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study
por: Wang, Jun-Wei, et al.
Publicado: (2022)

Therapeutic Strategies for Diabetes: Immune Modulation in Pancreatic β Cells
por: Jo, Sugyeong, et al.
Publicado: (2021)

Huobahuagen tablet improves renal function in diabetic kidney disease: a real-world retrospective cohort study
por: Tan, Ying, et al.
Publicado: (2023)

Development and validation of a Sarcopenia Geriatric Scale (SARCO-GS): a new short scale for the screening of sarcopenia
por: Rosas-Carrasco, Oscar, et al.
Publicado: (2023)

PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study
por: Du, Xin-Xing, et al.
Publicado: (2022)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
por: Tezuka, Yuta, et al.
Publicado: (2021)

Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study
por: Zhang, Kun, et al.
Publicado: (2020)

Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer
por: Xiong, Qi, et al.
Publicado: (2021)

Efficacy and Safety of Anlotinib in the Treatment of Small Cell Lung Cancer: A Real-World Observation Study
por: Yuan, Jing, et al.
Publicado: (2022)

A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma
por: Li, Qingqing, et al.
Publicado: (2022)

Transcriptomic Profiling of Human Placenta in Gestational Diabetes Mellitus at the Single-Cell Level
por: Yang, Yuqi, et al.
Publicado: (2021)

Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study
por: Zhong, Qiuxia, et al.
Publicado: (2021)

The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
por: Zheng, Hao-Ran, et al.
Publicado: (2022)

Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Pancreatitis
por: Zhang, Amy L., et al.
Publicado: (2021)

Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting
por: Maumus-Robert, Sandy, et al.
Publicado: (2023)

Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study
por: Liu, Xiao zhu, et al.
Publicado: (2023)

Regulation of autophagy by natural polyphenols in the treatment of diabetic kidney disease: therapeutic potential and mechanism
por: Liu, Tongtong, et al.
Publicado: (2023)

Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis
por: Mei, Wentong, et al.
Publicado: (2023)

Gaps of Medication Treatment Management Between Guidelines and Real-World for Inpatients With Type 2 Diabetes in China From Pharmacist’s Perspective
por: Song, Zhi-Hui, et al.
Publicado: (2022)

Quantitative Analysis of Proteome in Non-functional Pituitary Adenomas: Clinical Relevance and Potential Benefits for the Patients
por: Cheng, Tingting, et al.
Publicado: (2019)

Anlotinib-containing regimen for advanced small-cell lung cancer: A protocol of meta-analysis
por: Yu, Guocan, et al.
Publicado: (2021)

Naoxintong capsule delay the progression of diabetic kidney disease: A real-world cohort study
por: Zhang, Yuqing, et al.
Publicado: (2022)

Real-world adherence to toxicity management guidelines for immune checkpoint inhibitor-induced diabetes mellitus
por: Shen, Min, et al.
Publicado: (2023)

A Risk Stratification Model for Metastatic Lymph Nodes of Papillary Thyroid Cancer: A Retrospective Study Based on Sonographic Features
por: Ni, Xiaofeng, et al.
Publicado: (2022)

Nationwide Trends of Pediatric Obesity and BMI z-Score From 2017-2021 in China: Comparable Findings From Real-World Mobile- and Hospital-Based Data
por: Yang, Yan, et al.
Publicado: (2022)

Malignant mediastinal mesothelioma treated with anlotinib: a case report and review of the literature
por: Zhang, Yishi, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors-Related Thyroid Dysfunction: Epidemiology, Clinical Presentation, Possible Pathogenesis, and Management
por: Zhan, Ling, et al.
Publicado: (2021)

Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers
por: Shahnam, Adel, et al.
Publicado: (2023)

Absolute Neutrophil Count in the Peripheral Blood Predicts Prognosis in Lung Cancer Patients Treated with Anlotinib
por: Chen, Rong, et al.
Publicado: (2021)

Cumulative Live Birth Rate in Patients With Thin Endometrium: A Real-World Single-Center Experience
por: Bu, Zhiqin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vccp43rj2p2u9297m814pe5q7l